A discordant, falsely elevated cancer antigen (ca 19-9) result was obtained on one patient sample when diluted 1:3 on an immulite 2000 xpi instrument while using reagent lot 315.The discordant result was reported to the physician(s), who questioned it.The sample was tested in an alternate laboratory on an alternate platform, resulting lower.A new draw was obtained from the patient and was diluted with a dilution factor of 1:3 and tested on s/n: (b)(4), still resulting high.The original sample was sent to a supporting laboratory and was tested on an alternate immulite 2000 xpi instrument, also resulting high.It is unknown if the result from the alternate platform was reported to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely elevated ca 19-9 results.
|
The initial mdr 2432235-2016-00012 was filed on january 08, 2016.Additional information (02/26/2016): siemens requested the sample material from the customer for further investigation, but it was not provided.A siemens headquarters support center (hsc) specialist reviewed the patient data and indicated that they could not determine the cause of the event.The cause of the discordant, falsely elevated (b)(4) results on one patient sample is unknown.
|